Toomas Eisler

431 total citations
12 papers, 322 citations indexed

About

Toomas Eisler is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Toomas Eisler has authored 12 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 5 papers in Cellular and Molecular Neuroscience and 2 papers in Molecular Biology. Recurrent topics in Toomas Eisler's work include Parkinson's Disease Mechanisms and Treatments (5 papers), Nuclear Receptors and Signaling (3 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Toomas Eisler is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (5 papers), Nuclear Receptors and Signaling (3 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Toomas Eisler collaborates with scholars based in United States and Czechia. Toomas Eisler's co-authors include Donald B. Calne, Lin‐Whei Chuang, Donald F. Klein, Michael R. Liebowitz, Farouk Karoum, Richard Jed Wyatt, John G. Nutt, Russell P. Hall, Thomas N. Chase and D. B. Calne and has published in prestigious journals such as Neurology, The Medical Journal of Australia and Medical Clinics of North America.

In The Last Decade

Toomas Eisler

12 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toomas Eisler United States	8	177	147	55	40	38	12	322
L Scarzella Italy	7	211 1.2×	80 0.5×	37 0.7×	40 1.0×	32 0.8×	16	324
S. Bassi Italy	10	157 0.9×	143 1.0×	88 1.6×	65 1.6×	71 1.9×	26	391
T. Siirtola Finland	9	201 1.1×	109 0.7×	25 0.5×	22 0.6×	35 0.9×	19	329
J. K. Rinne Finland	7	90 0.5×	138 0.9×	80 1.5×	43 1.1×	47 1.2×	9	242
Tilak Mendis Canada	11	247 1.4×	98 0.7×	47 0.9×	36 0.9×	30 0.8×	15	414
M Iida Japan	7	123 0.7×	112 0.8×	82 1.5×	38 0.9×	53 1.4×	15	354
S Düby United States	7	209 1.2×	98 0.7×	43 0.8×	20 0.5×	38 1.0×	9	405
Govindan Gopinathan United States	11	274 1.5×	98 0.7×	28 0.5×	25 0.6×	10 0.3×	22	344
Jorge S. Mendez United States	7	149 0.8×	132 0.9×	61 1.1×	18 0.5×	16 0.4×	7	307
K. Jellinger Austria	9	220 1.2×	245 1.7×	122 2.2×	18 0.5×	60 1.6×	13	478

Countries citing papers authored by Toomas Eisler

Since Specialization

Citations

This map shows the geographic impact of Toomas Eisler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toomas Eisler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toomas Eisler more than expected).

Fields of papers citing papers by Toomas Eisler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toomas Eisler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toomas Eisler. The network helps show where Toomas Eisler may publish in the future.

Co-authorship network of co-authors of Toomas Eisler

This figure shows the co-authorship network connecting the top 25 collaborators of Toomas Eisler. A scholar is included among the top collaborators of Toomas Eisler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toomas Eisler. Toomas Eisler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Karoum, Farouk, Lin‐Whei Chuang, Toomas Eisler, et al.. (1982). Metabolism of (‐) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit. Neurology. 32(5). 503–503. 108 indexed citations

2.

Eisler, Toomas, et al.. (1981). Absorption of levodopa after rectal administration. Neurology. 31(2). 215–215. 25 indexed citations

3.

Eisler, Toomas, James M. Dambrosia, Irwin J. Kopin, & Donald B. Calne. (1981). Deprenyl in Parkinson disease. Neurology. 31(12). 1578–1578. 1 indexed citations

4.

Eisler, Toomas, Michael O. Thorner, Robert M. MacLeod, Donald L. Kaiser, & D. B. Calne. (1981). Prolactin secretion in Parkinson disease. Neurology. 31(10). 1356–1356. 37 indexed citations

5.

Eisler, Toomas, H. Teräväinen, H B Krebs, et al.. (1981). Deprenyl in Parkinson disease. Neurology. 31(1). 19–19. 60 indexed citations

6.

Eisler, Toomas, et al.. (1981). Erythromelalgia‐like eruption in parkinsonian patients treated with bromocriptine. Neurology. 31(10). 1368–1368. 29 indexed citations

7.

Eisler, Toomas, et al.. (1980). Progress in the pharmacotherapy of Parkinsonism.. PubMed. 23. 237–43. 2 indexed citations

8.

Calne, Donald B. & Toomas Eisler. (1979). The Pathogenesis and Medical Treatment of Extrapyramidal Disease. Medical Clinics of North America. 63(4). 715–727. 3 indexed citations

9.

Eisler, Toomas. (1979). Parkinsonism—New drugs and new approaches. Disease-a-Month. 25(6). 1–51. 1 indexed citations

10.

Eisler, Toomas. (1978). Muscle Fiber-Type Disproportion. Archives of Neurology. 35(12). 823–823. 14 indexed citations

11.

Calne, Donald B., Adrian C. Williams, John G. Nutt, et al.. (1978). Ergot Derivatives for Parkinsonism. The Medical Journal of Australia. 2(S2_Part2). 25–26. 7 indexed citations

12.

Nutt, John G., Arnold J. Rosin, Toomas Eisler, Donald B. Calne, & Thomas N. Chase. (1978). Effect of an Opiate Antagonist on Movement Disorders. Archives of Neurology. 35(12). 810–811. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact